HomeCompareGNGBY vs EQR

GNGBY vs EQR: Dividend Comparison 2026

GNGBY yields 2.32% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GNGBY wins by $124.05M in total portfolio value· pulled ahead in Year 3
10 years
GNGBY
GNGBY
● Live price
2.32%
Share price
$20.57
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124.10M
Annual income
$114,616,754.52
Full GNGBY calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — GNGBY vs EQR

📍 GNGBY pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNGBYEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNGBY + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNGBY pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNGBY
Annual income on $10K today (after 15% tax)
$197.38/yr
After 10yr DRIP, annual income (after tax)
$97,424,241.34/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, GNGBY beats the other by $97,419,587.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNGBY + EQR for your $10,000?

GNGBY: 50%EQR: 50%
100% EQR50/50100% GNGBY
Portfolio after 10yr
$62.07M
Annual income
$57,311,115.06/yr
Blended yield
92.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

GNGBY
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
2.6
Piotroski
6/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNGBY buys
0
EQR buys
0
No recent congressional trades found for GNGBY or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNGBYEQR
Forward yield2.32%5.87%
Annual dividend / share$0.48$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.8%
Portfolio after 10y$124.10M$47.8K
Annual income after 10y$114,616,754.52$5,475.61
Total dividends collected$123.36M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: GNGBY vs EQR ($10,000, DRIP)

YearGNGBY PortfolioGNGBY Income/yrEQR PortfolioEQR Income/yrGap
1$11,164$464.43$11,380$679.82$216.00EQR
2$12,915$969.18$13,014$837.25$99.00EQR
3← crossover$15,915$2,095.61$14,961$1,036.20+$954.00GNGBY
4$21,856$4,826.80$17,297$1,289.22+$4.6KGNGBY
5$35,775$12,389.91$20,121$1,613.15+$15.7KGNGBY
6$76,188$37,908.46$23,561$2,030.84+$52.6KGNGBY
7$232,420$150,898.52$27,783$2,573.54+$204.6KGNGBY
8$1,109,122$860,432.66$33,013$3,284.39+$1.08MGNGBY
9$8,861,597$7,674,836.93$39,547$4,223.51+$8.82MGNGBY
10$124,098,664$114,616,754.52$47,791$5,475.61+$124.05MGNGBY

GNGBY vs EQR: Complete Analysis 2026

GNGBYStock

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Full GNGBY Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this GNGBY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNGBY vs SCHDGNGBY vs JEPIGNGBY vs OGNGBY vs KOGNGBY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.